Electronic cigarettes as a smoking cessation aid for patients with cancer: beliefs and behaviours of clinicians in the UK.


Journal

BMJ open
ISSN: 2044-6055
Titre abrégé: BMJ Open
Pays: England
ID NLM: 101552874

Informations de publication

Date de publication:
19 11 2020
Historique:
entrez: 14 1 2021
pubmed: 15 1 2021
medline: 11 3 2021
Statut: epublish

Résumé

To explore UK clinicians' beliefs and behaviours around recommending e-cigarettes as a smoking cessation aid for patients with cancer. Cross-sectional online survey. England, Wales, Scotland and Northern Ireland. Clinicians involved in the care of patients with cancer. Behavioural Change Wheel capability, opportunity and motivation to perform a behaviour, knowledge, beliefs, current practice around e-cigarettes and other smoking cessation practices. Clinicians (n=506) completed an online survey to assess beliefs and behaviours around e-cigarettes and other smoking cessation practices for patients with cancer. Behavioural factors associated with recommending e-cigarettes in practice were assessed. 29% of clinicians would not recommend e-cigarettes to patients with cancer who continue to smoke. Factors associated with recommendation include smoking cessation knowledge (OR 1.56, 95% CI 1.01 to 2.44) and e-cigarette knowledge (OR 1.64, 95% CI 1.06 to 2.55), engagement with patients regarding smoking cessation (OR 2.12, 95% CI 1.12 to 4.03), belief in the effectiveness of e-cigarettes (OR 2.36 95% CI 1.61 to 3.47) and belief in sufficient evidence on e-cigarettes (OR 2.08 95% CI 1.10 to 4.00) and how comfortable they felt discussing e-cigarettes with patients (OR 1.57 95% CI 1.04 to 2.36). Many clinicians providing cancer care to patients who smoke do not recommend e-cigarettes as a smoking cessation aid and were unaware of national guidance supporting recommendation of e-cigarettes as a smoking cessation aid.

Identifiants

pubmed: 33444179
pii: bmjopen-2020-037637
doi: 10.1136/bmjopen-2020-037637
pmc: PMC7678366
doi:

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

e037637

Subventions

Organisme : Cancer Research UK
ID : A24355
Pays : United Kingdom

Informations de copyright

© Author(s) (or their employer(s)) 2020. Re-use permitted under CC BY. Published by BMJ.

Déclaration de conflit d'intérêts

Competing interests: None declared.

Références

BMC Med. 2016 Apr 05;14:62
pubmed: 27044418
Ann Fam Med. 2017 Sep;15(5):443-450
pubmed: 28893814
J Thorac Oncol. 2011 Jun;6(6):1059-65
pubmed: 21512406
Implement Sci. 2017 Sep 15;12(1):114
pubmed: 28915815
BMC Cancer. 2017 May 19;17(1):348
pubmed: 28526000
Tob Control. 2017 Jul;26(4):440-445
pubmed: 27903958
Cancer. 2014 Feb 15;120(4):562-9
pubmed: 24496870
Curr Addict Rep. 2019 Jun;6(2):75-85
pubmed: 31555499
J Community Hosp Intern Med Perspect. 2017 Jul 13;7(3):144-150
pubmed: 28808506
Lung Cancer. 2009 Nov;66(2):218-25
pubmed: 19321223
Addiction. 2016 Sep;111(9):1536-53
pubmed: 27003925
Clin Med (Lond). 2012 Feb;12(1):59-62
pubmed: 22372226
JAMA. 2011 Jun 22;305(24):2548-55
pubmed: 21693743
BMJ. 1998 Jun 20;316(7148):1878-81
pubmed: 9632409
Br J Cancer. 2017 Oct 10;117(8):1224-1232
pubmed: 28898236
J Clin Oncol. 2012 Jun 10;30(17):2102-11
pubmed: 22565003
BMJ. 2010 Jan 21;340:b5569
pubmed: 20093278
Br J Gen Pract. 2019 Jan;69(678):e8-e14
pubmed: 30397013
J Clin Oncol. 2015 Mar 10;33(8):885-93
pubmed: 25646196
Cochrane Database Syst Rev. 2014;(12):CD010216
pubmed: 25515689
Addiction. 2014 Nov;109(11):1801-10
pubmed: 25078252
Curr Cardiol Rep. 2019 Aug 28;21(10):111
pubmed: 31463564
N Engl J Med. 2019 Feb 14;380(7):629-637
pubmed: 30699054
Int J Radiat Oncol Biol Phys. 2008 Oct 1;72(2):433-40
pubmed: 18448268
Addict Behav. 2016 Sep;60:78-83
pubmed: 27100472
Int J Cancer. 2013 Jan 15;132(2):401-10
pubmed: 22539012
Implement Sci. 2011 Apr 23;6:42
pubmed: 21513547
J Natl Cancer Inst. 2007 Mar 7;99(5):365-75
pubmed: 17341728
Respir Res. 2016 May 17;17(1):55
pubmed: 27184050
J Thorac Oncol. 2013 May;8(5):543-8
pubmed: 23529191
Int J Environ Res Public Health. 2018 Nov 07;15(11):
pubmed: 30405035
Ann Surg Oncol. 2012 May;19(5):1430-8
pubmed: 22065194

Auteurs

Jo Brett (J)

Health & Life Sciences, Oxford Brookes University, Oxford, UK jbrett@brookes.ac.uk.

Emma L Davies (EL)

Department of Psychology, Social Workand Public Health Oxford Brookes University, Oxford, UK.

Fiona Matley (F)

Health & Life Sciences, Oxford Brookes University, Oxford, UK.

Paul Aveyard (P)

Nuffield Department of Primary Care Health Sciences, University of Oxford, Oxford, UK.

Mary Wells (M)

Department of Surgery & Cancer, Faculty of Medicine, Imperial College Healthcare NHS Trust, London, UK.

David Foxcroft (D)

Department of Psychology, Social Workand Public Health Oxford Brookes University, Oxford, UK.

Brian Nicholson (B)

Nuffield Department of Primary Care Health Sciences, University of Oxford, Oxford, UK.

Shiroma De Silva Minor (S)

Cancer Centre, Oxford University Hospitals NHS Foundation Trust, Oxford, UK.

Lesley Sinclair (L)

Molecular, Genetic and Population Health Sciences, University of Edinburgh, Edinburgh, Scotland.

Sarah Jakes (S)

Vaper Representative, London, UK.

Eila Watson (E)

Health & Life Sciences, Oxford Brookes University, Oxford, UK.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH